Atlas Trials

High-risk GD2-Positive Ewing Sarcoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High-risk GD2-Positive Ewing Sarcoma

RecordFirmDate
International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma (NCT06839703)Prof. Dr. Dirk Reinhardt2025-03-01

Track High-risk GD2-Positive Ewing Sarcoma automatically

Every clearance here is in the API, with alerts when new ones post.